Since Dok1 has been described as a candidate tumor suppressor [45], [48] and work from our laboratory and others indicate that BRK has oncogenic properties [28], [49], we opted to investigate the functional link between BRK and Dok1. The gene discussed is DOK1; the disease is neoplasm.